2:01 PM EDT
Bill Cassidy M.D., R-LA 6th

Mr. CASSIDY. Mr. Chairman, I cannot understand why somebody would object to this. The bill is about transparency, and this amplifies that transparency. EPA can impose rules which cost tens or even hundreds of billions of dollars on the U.S. economy. Those expenses translate into jobs lost.

Having access to the underlying information, and the estimates of cost and benefits, is critical to know why that is. And as my colleague said, there is no reason to have to reveal information about individuals. And let me just point to the medical literature. In the medical literature, there is a push that when the Federal Government funds research, that that underlying data is made subject, is made available to the general public. When the FDA reviews drugs, FDA will look at underlying data.

So why would we require it for medications, which obviously affect many people, but not for the EPA. Having methodology which is transparent is absolutely essential in modern scientific literature. I don't see why there is an objection to it unless the hope is that EPA can satisfy an ideological bent without having to justify it.

This amendment will provide more transparency for EPA's billion-dollar rules. I urge my colleagues to vote ``yes'' on the amendment and ``yes'' on the underlying bill. The American people cannot afford to have jobs shipped overseas or have their economy otherwise wrecked. More rationality, transparency, and accountability must be brought to the EPA and its rulemaking process.